CHANTAL NAVALAH: Open Payments
NPI 1144608654 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,898 in 60 payments from 13 companies in 2025. Trend: 2023 $971 · 2024 $526 · 2025 $1,898
Food & beverage: $1,898
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 15 | $433 |
| CVRx, Inc. | 8 | $336 |
| BridgeBio Pharma, Inc. | 7 | $336 |
| AstraZeneca Pharmaceuticals LP | 5 | $215 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 8 | $183 |
| Novartis Pharmaceuticals Corporation | 5 | $102 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $86 |
| Alnylam Pharmaceuticals Inc. | 3 | $66 |
| Boston Scientific Corporation | 2 | $51 |
| Philips North America LLC | 1 | $33 |
Products named: VYNDAQEL, Barostim Neo System, Attruby, LifeVest, WAINUA, LEQVIO, Kerendia, AMVUTTRA.
Industry payments across GA — which companies pay providers there.
